Management of Contralateral Breast and Axillary Nodes Silicone Migration after Implant Rupture
Background:. Silicone implants were developed in 1962 for breast augmentation and became essential in reconstruction after mastectomy. Silicone “bleeding” has been described from both ruptured and intact implants and can induce disseminated granulomatosis due to the component's high fat solubil...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2022-05-01
|
Series: | Plastic and Reconstructive Surgery, Global Open |
Online Access: | http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000004290 |
_version_ | 1817981034920148992 |
---|---|
author | Leslie Elahi, MD Marie-Garance Meuwly Jean-Yves Meuwly, MD Wassim Raffoul, MD, PD, MER Natalie Koch, MD |
author_facet | Leslie Elahi, MD Marie-Garance Meuwly Jean-Yves Meuwly, MD Wassim Raffoul, MD, PD, MER Natalie Koch, MD |
author_sort | Leslie Elahi, MD |
collection | DOAJ |
description | Background:. Silicone implants were developed in 1962 for breast augmentation and became essential in reconstruction after mastectomy. Silicone “bleeding” has been described from both ruptured and intact implants and can induce disseminated granulomatosis due to the component's high fat solubility. If not adequately treated, they can lead to disastrous cosmetic and functional consequences. Because they may mimic malignancy, prompt and reliable diagnosis should be made as early as possible.
Methods:. We present a clinical case description of multiple intraparenchymal and ipsi/contralateral intraganglionic siliconomas in a woman who had undergone breast reconstruction, and a literature review of the pathophysiology of siliconomas and their diagnosis and management.
Results:. Silicone migration to the contralateral breast and lymph node is rare and has seldom been described. The mechanism is still debated. Excluding malignancy is a priority, and systematic management must be respected to avoid misdiagnosis or unnecessary investigations.
Conclusions:. A multidisciplinary approach is essential for siliconoma management. Silicone-related lymphadenopathies do not require follow-up or special treatment unless they interfere with the diagnosis of tumor recurrence. Careful observation is sufficient for asymptomatic siliconomas; however, symptomatic ones should be treated depending on skin involvement and the patient's eligibility for intervention. |
first_indexed | 2024-04-13T23:00:42Z |
format | Article |
id | doaj.art-5d6e9507251b467b8d8f664c915d9cad |
institution | Directory Open Access Journal |
issn | 2169-7574 |
language | English |
last_indexed | 2024-04-13T23:00:42Z |
publishDate | 2022-05-01 |
publisher | Wolters Kluwer |
record_format | Article |
series | Plastic and Reconstructive Surgery, Global Open |
spelling | doaj.art-5d6e9507251b467b8d8f664c915d9cad2022-12-22T02:25:50ZengWolters KluwerPlastic and Reconstructive Surgery, Global Open2169-75742022-05-01105e429010.1097/GOX.0000000000004290202205000-00059Management of Contralateral Breast and Axillary Nodes Silicone Migration after Implant RuptureLeslie Elahi, MD0Marie-Garance Meuwly1Jean-Yves Meuwly, MD2Wassim Raffoul, MD, PD, MER3Natalie Koch, MD4From the * Department of Plastic, Reconstructive and Hand Surgery, University Hospital of Lausanne (CHUV), Lausanne, SwitzerlandFrom the * Department of Plastic, Reconstructive and Hand Surgery, University Hospital of Lausanne (CHUV), Lausanne, Switzerland† Department of Diagnostic and Interventional Radiology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.From the * Department of Plastic, Reconstructive and Hand Surgery, University Hospital of Lausanne (CHUV), Lausanne, SwitzerlandFrom the * Department of Plastic, Reconstructive and Hand Surgery, University Hospital of Lausanne (CHUV), Lausanne, SwitzerlandBackground:. Silicone implants were developed in 1962 for breast augmentation and became essential in reconstruction after mastectomy. Silicone “bleeding” has been described from both ruptured and intact implants and can induce disseminated granulomatosis due to the component's high fat solubility. If not adequately treated, they can lead to disastrous cosmetic and functional consequences. Because they may mimic malignancy, prompt and reliable diagnosis should be made as early as possible. Methods:. We present a clinical case description of multiple intraparenchymal and ipsi/contralateral intraganglionic siliconomas in a woman who had undergone breast reconstruction, and a literature review of the pathophysiology of siliconomas and their diagnosis and management. Results:. Silicone migration to the contralateral breast and lymph node is rare and has seldom been described. The mechanism is still debated. Excluding malignancy is a priority, and systematic management must be respected to avoid misdiagnosis or unnecessary investigations. Conclusions:. A multidisciplinary approach is essential for siliconoma management. Silicone-related lymphadenopathies do not require follow-up or special treatment unless they interfere with the diagnosis of tumor recurrence. Careful observation is sufficient for asymptomatic siliconomas; however, symptomatic ones should be treated depending on skin involvement and the patient's eligibility for intervention.http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000004290 |
spellingShingle | Leslie Elahi, MD Marie-Garance Meuwly Jean-Yves Meuwly, MD Wassim Raffoul, MD, PD, MER Natalie Koch, MD Management of Contralateral Breast and Axillary Nodes Silicone Migration after Implant Rupture Plastic and Reconstructive Surgery, Global Open |
title | Management of Contralateral Breast and Axillary Nodes Silicone Migration after Implant Rupture |
title_full | Management of Contralateral Breast and Axillary Nodes Silicone Migration after Implant Rupture |
title_fullStr | Management of Contralateral Breast and Axillary Nodes Silicone Migration after Implant Rupture |
title_full_unstemmed | Management of Contralateral Breast and Axillary Nodes Silicone Migration after Implant Rupture |
title_short | Management of Contralateral Breast and Axillary Nodes Silicone Migration after Implant Rupture |
title_sort | management of contralateral breast and axillary nodes silicone migration after implant rupture |
url | http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000004290 |
work_keys_str_mv | AT leslieelahimd managementofcontralateralbreastandaxillarynodessiliconemigrationafterimplantrupture AT mariegarancemeuwly managementofcontralateralbreastandaxillarynodessiliconemigrationafterimplantrupture AT jeanyvesmeuwlymd managementofcontralateralbreastandaxillarynodessiliconemigrationafterimplantrupture AT wassimraffoulmdpdmer managementofcontralateralbreastandaxillarynodessiliconemigrationafterimplantrupture AT nataliekochmd managementofcontralateralbreastandaxillarynodessiliconemigrationafterimplantrupture |